Clinical Trial Update: Study of the Resvent RXiBreeze™ PAP System to Treat Obstructive Sleep Apnea [NA]

View source ↗

Summary

The clinical trial evaluating the Resvent RXiBreeze PAP System for obstructive sleep apnea has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstructive Sleep Apnea

Drugs mentioned

• Resvent RXiBreeze PAP System

Snippet

Sponsor: Resvent Holding USA LTD | Conditions: Obstructive Sleep Apnea | NA | Status: COMPLETED